Aemetis (AMTX) Stock Forecast, Price Target & Predictions
AMTX Stock Forecast
Aemetis stock forecast is as follows: an average price target of $3.88 (represents a 59.67% upside from AMTX’s last price of $2.43) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
AMTX Price Target
The average price target for Aemetis (AMTX) is $3.88 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $4.25 to $3.50. This represents a potential 59.67% upside from AMTX's last price of $2.43.
AMTX Analyst Ratings
According to 9 Wall Street analysts, Aemetis's rating consensus is 'Buy'. The analyst rating breakdown for AMTX stock is 0 'Strong Buy' (0.00%), 6 'Buy' (66.67%), 1 'Hold' (11.11%), 2 'Sell' (22.22%), and 0 'Strong Sell' (0.00%).
Aemetis Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 30, 2024 | Jirdan Levy | Truist Financial | $3.50 | $3.42 | 2.34% | 44.03% |
| May 13, 2024 | Jordan Levy | Truist Financial | $4.00 | $4.06 | -1.48% | 64.61% |
| Feb 01, 2023 | - | Truist Financial | $5.00 | $4.67 | 7.07% | 105.76% |
| Dec 14, 2022 | - | UBS | $4.25 | $4.43 | -4.06% | 74.90% |
| Aug 08, 2022 | Jordan Levy | Truist Financial | $12.00 | $11.12 | 7.91% | 393.83% |
The latest Aemetis stock forecast, released on Jul 30, 2024 by Jirdan Levy from Truist Financial, set a price target of $3.50, which represents a 2.34% increase from the stock price at the time of the forecast ($3.42), and a 44.03% increase from AMTX last price ($2.43).
Aemetis Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 2 |
| Avg Price Target | - | $3.50 | $3.75 |
| Last Closing Price | $2.43 | $2.43 | $2.43 |
| Upside/Downside | -100.00% | 44.03% | 54.32% |
In the current month, the average price target of Aemetis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aemetis's last price of $2.43. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 16, 2023 | Keefe, Bruyette & Woods | - | Market Perform | Downgrade |
| Aug 16, 2023 | Wolfe Research | - | Peer Perform | Downgrade |
| Aug 16, 2023 | Argus Research | - | Sell | Downgrade |
| Aug 16, 2023 | BTIG | - | Sell | Downgrade |
| Aug 16, 2023 | UBS | Neutral | Buy | Upgrade |
| Aug 16, 2023 | Citigroup | - | Overweight | Upgrade |
| Aug 16, 2023 | Evercore ISI | - | Outperform | Upgrade |
| Aug 16, 2023 | Benchmark | - | Speculative Buy | Upgrade |
| Aug 16, 2023 | BMO Capital | - | Outperform | Upgrade |
| Dec 14, 2022 | UBS | - | Neutral | Initialise |
Aemetis's last stock rating was published by Keefe, Bruyette & Woods on Aug 16, 2023. The company Downgrade its AMTX rating from "null" to "Market Perform".
Aemetis Financial Forecast
Aemetis Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $70.76M | $68.69M | $45.11M | $2.15M | $66.73M | $71.83M | - | $52.05M | $49.90M | $54.88M | $42.81M | $40.92M | $47.82M | $39.48M | $57.39M | $50.62M | $41.89M | $44.63M |
| Avg Forecast | $216.10M | $209.99M | $188.71M | $181.94M | $124.56M | $111.82M | $100.92M | $98.26M | $86.56M | $77.36M | $73.81M | $77.22M | $74.65M | $75.50M | $51.37M | $59.52M | $71.45M | $67.40M | $59.23M | $48.05M | $46.31M | $54.97M | $29.88M | $360.94M | $148.25M | $28.74M | $53.69M | $35.35M | $27.93M | $43.10M |
| High Forecast | $241.85M | $235.01M | $211.20M | $203.62M | $139.40M | $125.14M | $112.94M | $109.96M | $96.88M | $83.98M | $82.60M | $86.42M | $98.81M | $84.50M | $57.49M | $66.62M | $79.96M | $75.43M | $59.23M | $57.65M | $55.57M | $65.96M | $35.86M | $433.13M | $177.91M | $34.49M | $64.42M | $42.42M | $33.51M | $51.72M |
| Low Forecast | $186.05M | $180.79M | $162.47M | $156.64M | $107.24M | $96.27M | $86.88M | $84.59M | $74.53M | $70.75M | $63.54M | $66.48M | $52.49M | $65.00M | $44.23M | $51.25M | $61.51M | $58.03M | $59.23M | $38.44M | $37.05M | $43.98M | $23.91M | $288.75M | $118.60M | $22.99M | $42.95M | $28.28M | $22.34M | $34.48M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 7 | 9 | 20 | 14 | 12 | 11 | 7 | 10 | 15 | 20 | 16 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.91% | 0.88% | 0.04% | 0.93% | 1.07% | - | 1.08% | 1.08% | 1.00% | 1.43% | 0.11% | 0.32% | 1.37% | 1.07% | 1.43% | 1.50% | 1.04% |
Aemetis's average Quarter revenue forecast for Mar 24 based on 4 analysts is $77.22M, with a low forecast of $66.48M, and a high forecast of $86.42M. AMTX's average Quarter revenue forecast represents a 9.12% increase compared to the company's last Quarter revenue of $70.76M (Dec 23).
Aemetis EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 7 | 9 | 20 | 14 | 12 | 11 | 7 | 10 | 15 | 20 | 16 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-7.20M | $-8.53M | $-7.79M | $-14.02M | $-8.65M | $-9.23M | - | $-12.21M | $-9.65M | $-1.97M | $-8.80M | $-3.39M | $10.26M | $-4.61M | $-126.00K | $-6.24M | $-4.52M | $-45.00K |
| Avg Forecast | $-16.12M | $-15.66M | $-14.07M | $-13.57M | $-9.29M | $-8.34M | $-7.53M | $-7.33M | $-6.46M | $-5.77M | $-5.50M | $-5.76M | $-5.57M | $-5.63M | $-3.83M | $-4.44M | $-5.33M | $-12.01M | $-4.42M | $-7.69M | $-10.92M | $-5.53M | $-7.50M | $-29.91M | $21.44M | $-2.89M | $720.62K | $-3.28M | $-1.97M | $720.32K |
| High Forecast | $-13.88M | $-13.48M | $-12.12M | $-11.68M | $-8.00M | $-7.18M | $-6.48M | $-6.31M | $-5.56M | $-5.28M | $-4.74M | $-4.96M | $-3.91M | $-4.85M | $-3.30M | $-3.82M | $-4.59M | $-9.61M | $-4.42M | $-6.16M | $-8.74M | $-4.42M | $-6.00M | $-23.93M | $25.73M | $-2.31M | $864.74K | $-2.62M | $-1.58M | $864.38K |
| Low Forecast | $-18.04M | $-17.53M | $-15.75M | $-15.19M | $-10.40M | $-9.33M | $-8.42M | $-8.20M | $-7.23M | $-6.26M | $-6.16M | $-6.45M | $-7.37M | $-6.30M | $-4.29M | $-4.97M | $-5.96M | $-14.41M | $-4.42M | $-9.23M | $-13.10M | $-6.63M | $-9.00M | $-35.89M | $17.15M | $-3.47M | $576.50K | $-3.93M | $-2.37M | $576.26K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.29% | 1.51% | 2.03% | 3.16% | 1.62% | 0.77% | - | 1.59% | 0.88% | 0.36% | 1.17% | 0.11% | 0.48% | 1.60% | -0.17% | 1.90% | 2.29% | -0.06% |
12 analysts predict AMTX's average Quarter EBITDA for Sep 20 to be $-29.91M, with a high of $-23.93M and a low of $-35.89M. This is -391.62% lower than Aemetis's previous annual EBITDA (Jun 20) of $10.26M.
Aemetis Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 7 | 9 | 20 | 14 | 12 | 11 | 7 | 10 | 15 | 20 | 16 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-25.44M | $30.71M | $-25.28M | $-26.41M | $-22.41M | $-69.84M | - | $-18.29M | $-17.60M | $-10.56M | $-18.11M | $-12.22M | $2.19M | $-12.05M | $-6.33M | $-12.94M | $-9.73M | $-5.86M |
| Avg Forecast | $4.00M | $4.52M | $1.25M | $146.97K | $-3.30M | $-5.14M | $-8.63M | $-11.23M | $-16.71M | $-17.84M | $-19.31M | $-20.42M | $-17.12M | $-13.41M | $-14.60M | $-18.65M | $-13.43M | $-17.86M | $-12.24M | $-11.26M | $-16.23M | $-12.58M | $-12.64M | $-107.75M | $4.58M | $-7.55M | $-5.89M | $-8.09M | $-5.35M | $-5.65M |
| High Forecast | $4.62M | $5.22M | $1.44M | $169.74K | $-2.71M | $-4.21M | $-7.07M | $-9.20M | $-13.69M | $-14.99M | $-15.82M | $-16.73M | $-7.34M | $-10.99M | $-11.96M | $-15.28M | $-11.01M | $-14.29M | $-12.24M | $-9.01M | $-12.99M | $-10.06M | $-10.12M | $-86.20M | $5.50M | $-6.04M | $-4.71M | $-6.47M | $-4.28M | $-4.52M |
| Low Forecast | $3.27M | $3.70M | $1.02M | $120.41K | $-3.82M | $-5.93M | $-9.96M | $-12.97M | $-19.29M | $-20.70M | $-22.30M | $-23.59M | $-32.29M | $-15.49M | $-16.86M | $-21.54M | $-15.52M | $-21.43M | $-12.24M | $-13.51M | $-19.48M | $-15.09M | $-15.17M | $-129.30M | $3.67M | $-9.06M | $-7.07M | $-9.70M | $-6.42M | $-6.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.49% | -2.29% | 1.73% | 1.42% | 1.67% | 3.91% | - | 1.63% | 1.08% | 0.84% | 1.43% | 0.11% | 0.48% | 1.60% | 1.07% | 1.60% | 1.82% | 1.04% |
Aemetis's average Quarter net income forecast for Dec 23 is $-17.12M, with a range of $-32.29M to $-7.34M. AMTX's average Quarter net income forecast represents a -155.76% decrease compared to the company's last Quarter net income of $30.71M (Sep 23).
Aemetis SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 7 | 9 | 20 | 14 | 12 | 11 | 7 | 10 | 15 | 20 | 16 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $9.79M | $8.98M | $9.71M | $10.79M | $7.52M | $6.87M | - | $7.31M | $5.09M | $5.75M | $5.38M | $4.56M | $4.05M | $3.94M | $4.53M | $3.94M | $4.24M | $3.89M |
| Avg Forecast | $26.89M | $26.13M | $23.48M | $22.64M | $15.50M | $13.91M | $12.56M | $12.22M | $10.77M | $9.63M | $9.18M | $9.61M | $9.29M | $9.39M | $6.39M | $7.41M | $8.89M | $5.16M | $7.37M | $4.50M | $4.69M | $6.85M | $3.76M | $40.25M | $8.46M | $2.46M | $4.22M | $2.47M | $2.33M | $3.75M |
| High Forecast | $30.09M | $29.24M | $26.28M | $25.33M | $17.34M | $15.57M | $14.05M | $13.68M | $12.05M | $10.45M | $10.28M | $10.75M | $12.29M | $10.51M | $7.15M | $8.29M | $9.95M | $6.19M | $7.37M | $5.40M | $5.63M | $8.23M | $4.51M | $48.29M | $10.16M | $2.96M | $5.06M | $2.96M | $2.80M | $4.50M |
| Low Forecast | $23.15M | $22.49M | $20.21M | $19.49M | $13.34M | $11.98M | $10.81M | $10.52M | $9.27M | $8.80M | $7.91M | $8.27M | $6.53M | $8.09M | $5.50M | $6.38M | $7.65M | $4.13M | $7.37M | $3.60M | $3.75M | $5.48M | $3.01M | $32.20M | $6.77M | $1.97M | $3.37M | $1.97M | $1.87M | $3.00M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 0.96% | 1.52% | 1.46% | 0.85% | 1.33% | - | 1.63% | 1.08% | 0.84% | 1.43% | 0.11% | 0.48% | 1.60% | 1.07% | 1.60% | 1.82% | 1.04% |
Aemetis's average Quarter SG&A projection for Mar 24 is $9.61M, based on 4 Wall Street analysts, with a range of $8.27M to $10.75M. The forecast indicates a -1.83% fall compared to AMTX last annual SG&A of $9.79M (Dec 23).
Aemetis EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 7 | 9 | 20 | 14 | 12 | 11 | 7 | 10 | 15 | 20 | 16 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.64 | $0.79 | $-0.68 | $-0.73 | $-0.63 | $-2.01 | - | $-0.54 | $-0.79 | $-0.30 | $-0.69 | $-0.99 | $0.11 | $-0.58 | $-0.31 | $-0.63 | $-0.52 | $-0.29 |
| Avg Forecast | $0.09 | $0.10 | $0.03 | - | $-0.07 | $-0.12 | $-0.19 | $-0.25 | $-0.38 | $-0.40 | $-0.43 | $-0.46 | $-0.39 | $-0.30 | $-0.33 | $-0.42 | $-0.30 | $-0.32 | $-0.29 | $1.43 | $1.25 | $1.01 | $-0.37 | $-0.44 | $-0.65 | $-0.21 | $-0.27 | $-0.28 | $-0.18 | $-0.27 |
| High Forecast | $0.10 | $0.12 | $0.03 | - | $-0.06 | $-0.09 | $-0.16 | $-0.21 | $-0.31 | $-0.34 | $-0.36 | $-0.38 | $-0.17 | $-0.25 | $-0.27 | $-0.34 | $-0.25 | $-0.26 | $-0.29 | $1.65 | $1.44 | $1.17 | $-0.30 | $-0.35 | $-0.52 | $-0.17 | $-0.22 | $-0.22 | $-0.14 | $-0.22 |
| Low Forecast | $0.07 | $0.08 | $0.02 | - | $-0.09 | $-0.13 | $-0.22 | $-0.29 | $-0.43 | $-0.47 | $-0.50 | $-0.53 | $-0.73 | $-0.35 | $-0.38 | $-0.48 | $-0.35 | $-0.37 | $-0.29 | $1.19 | $1.03 | $0.84 | $-0.44 | $-0.53 | $-0.78 | $-0.26 | $-0.32 | $-0.33 | $-0.21 | $-0.32 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.66% | -2.62% | 2.07% | 1.74% | 2.08% | 6.31% | - | -0.38% | -0.63% | -0.30% | 1.86% | 2.25% | -0.17% | 2.76% | 1.15% | 2.25% | 2.89% | 1.07% |
According to 5 Wall Street analysts, Aemetis's projected average Quarter EPS for Dec 23 is $-0.39, with a low estimate of $-0.73 and a high estimate of $-0.17. This represents a -148.80% decrease compared to AMTX previous annual EPS of $0.79 (Sep 23).
Aemetis Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| VTNR | Vertex Energy | $0.42 | $9.60 | 2185.71% | Hold |
| CLNE | Clean Energy Fuels | $3.11 | $5.00 | 60.77% | Strong Buy |
| AMTX | Aemetis | $2.43 | $3.88 | 59.67% | Buy |
| PARR | Par Pacific | $19.40 | $28.67 | 47.78% | Buy |
| PBF | PBF Energy | $33.07 | $45.18 | 36.62% | Buy |
| DINO | HF Sinclair | $46.54 | $58.88 | 26.51% | Buy |
| DK | Delek US | $20.11 | $22.88 | 13.77% | Hold |
| VLO | Valero Energy | $135.80 | $148.92 | 9.66% | Buy |
| SUN | Sunoco LP | $54.23 | $54.60 | 0.68% | Buy |
| PSX | Phillips 66 | $128.30 | $124.50 | -2.96% | Buy |
| MPC | Marathon Petroleum | $163.87 | $158.80 | -3.09% | Buy |
| CVI | CVR Energy | $23.78 | $21.33 | -10.30% | Buy |
AMTX Forecast FAQ
Is Aemetis a good buy?
Yes, according to 9 Wall Street analysts, Aemetis (AMTX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 66.67% of AMTX's total ratings.
What is AMTX's price target?
Aemetis (AMTX) average price target is $3.88 with a range of $3.5 to $4.25, implying a 59.67% from its last price of $2.43. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Aemetis stock go up soon?
According to Wall Street analysts' prediction for AMTX stock, the company can go up by 59.67% (from the last price of $2.43 to the average price target of $3.88), up by 74.90% based on the highest stock price target, and up by 44.03% based on the lowest stock price target.
Can Aemetis stock reach $4?
AMTX's highest twelve months analyst stock price target of $4.25 supports the claim that Aemetis can reach $4 in the near future.
What are Aemetis's analysts' financial forecasts?
Aemetis's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $435.55M (high $487.45M, low $374.99M), average EBITDA is $-32.483M (high $-27.966M, low $-36.353M), average net income is $-28.301M (high $-23.185M, low $-32.685M), average SG&A $54.19M (high $60.64M, low $46.65M), and average EPS is $-0.637 (high $-0.522, low $-0.736). AMTX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $796.75M (high $891.68M, low $685.96M), average EBITDA is $-59.42M (high $-51.157M, low $-66.5M), average net income is $9.91M (high $11.45M, low $8.12M), average SG&A $99.13M (high $110.94M, low $85.34M), and average EPS is $0.223 (high $0.258, low $0.183).
Did the AMTX's actual financial results beat the analysts' financial forecasts?
Based on Aemetis's last annual report (Dec 2023), the company's revenue was $186.72M, which missed the average analysts forecast of $261.05M by -28.47%. Apple's EBITDA was $-30.396M, beating the average prediction of $-19.468M by 56.13%. The company's net income was $-46.42M, missing the average estimation of $-63.785M by -27.22%. Apple's SG&A was $39.27M, beating the average forecast of $32.48M by 20.90%. Lastly, the company's EPS was $-1.22, missing the average prediction of $-1.436 by -15.04%. In terms of the last quarterly report (Dec 2023), Aemetis's revenue was $70.76M, missing the average analysts' forecast of $74.65M by -5.21%. The company's EBITDA was $-7.198M, beating the average prediction of $-5.567M by 29.29%. Aemetis's net income was $-25.442M, beating the average estimation of $-17.125M by 48.57%. The company's SG&A was $9.79M, beating the average forecast of $9.29M by 5.37%. Lastly, the company's EPS was $-0.64, beating the average prediction of $-0.386 by 66.00%